Proteasome Functioning in Breast Cancer: Connection with Clinical-Pathological Factors

Chymotrypsin-like activity and subunit composition of proteasomes in human cancers

(2014) I. V. Kondakova et al.   MOLECULAR BIOLOGY

Changes in Proteasome Chymotrypsin-Like Activity during the Development of Human Mammary and Thyroid Carcinomas

(2013) E. E. Shashova et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Role of microRNAs in breast cancer

(2013) Ramesh Singh et al.   CANCER BIOLOGY & THERAPY

A novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancer-associated fibroblasts by breast cancer cells

(2013) Jing Xu et al.   CANCER LETTERS

MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer

(2013) Neha Nagpal et al.   CARCINOGENESIS

Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia

(2013) X-W Yang et al.   ONCOGENE

Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status

(2013) Gianpiero Di Leva et al.   PLoS Genetics

Emerging roles of the ubiquitin-proteasome system in the steroid receptor signaling

(2012) Jung Hoon Lee et al.   ARCHIVES OF PHARMACAL RESEARCH

Expression of vascular endothelial growth factor and transcription factors HIF-1, NF-kB expression in squamous cell carcinoma of head and neck; association with proteasome and calpain activities

(2012) Liudmila V. Spirina et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Association of growth factors, HIF-1 and NF-κB expression with proteasomes in endometrial cancer

(2012) Ludmila V. Spirina et al.   MOLECULAR BIOLOGY REPORTS

Proteasome activity in tumors of the female reproductive system

(2012) I. V. Kondakova et al.   RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY

ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer

(2012) Irene K. Guttilla et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia

(2011) G. Aue et al.   BLOOD

Pattern of MHC class I and immune proteasome expression in Walker 256 tumor during growth and regression in Brattleboro rats with the hereditary defect of arginine-vasopressin synthesis

(2011) Liudmila A. Zakharova et al.   CELLULAR IMMUNOLOGY

MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer

(2011) Cathy A. Andorfer et al.   TRENDS IN MOLECULAR MEDICINE

The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes

(2010) Andrew M. Pickering et al.   BIOCHEMICAL JOURNAL

The proteasome: Overview of structure and functions

(2009) Keiji TANAKA   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

p53 represses c-Myc through induction of the tumor suppressor miR-145

(2009) M. Sachdeva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The UPS: a promising target for breast cancer treatment

(2008) Ko Sato et al.   BMC BIOCHEMISTRY

Implications of applied research for prognosis and therapy of breast cancer

(2008) M.F. Barginear et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY